Search Results

Johnson & Johnson MedTech’s Impella 5.5 and Impella CP Receive Expanded Indications to Treat Pediatric Patients

December 12, 2024—Johnson & Johnson MedTech announced that the FDA has expanded the indications for the Impella 5.5 with SmartAssist and Impella CP with SmartAssist heart pumps, granting premarket approval (PMA) for use in specific pediatric patients with symptomatic acute decompensated heart failure and cardiogenic shock.

FDA Advisory Panel to Review Angel Medical's Implantable Device to Detect Heart Attack

February 8, 2016—Angel Medical Systems Inc. has announced that the Circulatory System Devices Panel of the US Food and Drug Administration will review the company's premarket approval (PMA) application for the AngelMed Guardian system at a meeting on Wednesday, March 16, 2016.

Prolocor Receives Funds From Seed Round and NIH SBIR Grant to Develop Thrombosis-Risk Prediction Tool

August 16, 2022—Prolocor, Inc., a health care startup developing a precision diagnostic test with the potential to predict the risk of thrombosis by quantifying FcγRIIa on the surface of platelets, announced the closing of an oversubscribed $3.2 million seed round.